Clinivation's Global Market Clearance services leverage our excellence in market clearance and many years of focused, successful experience in developing and supporting thousands of medtech market clearance applications in all of the major and emerging world markets. Our many years of successful experience spans from comprehensive initiation, support, and execution of the most complex Class III PMA programs to focused global market clearance initiatives.

MedicSight is an industry leader in the development of enterprise-wide computer-aided detection (CAD) software for use by the medical imaging community to aid in earlier detection of disease. MedicSight's patented software solutions have been validated against one of the world's largest and most population-diverse databases of verified CT scan data to help clinicians confidently identify, measure, and analyze suspicious pathology on CT scans of the colon and lung.

The company's CAD products include ColonCAD^™ for CT colonography and LungCAD^™ for CT scans of the thorax. Both products integrate with advanced visualization software. This feature allows clinical end users to perform either a 'second read' where CAD findings are displayed to the user after completion of an initial review of the CT scan data, or a 'concurrent read' where CAD findings are available to the end user during their initial review of the CT scan images, providing a CAD solution that can be matched to individual workflow requirements and productivity.

Headquartered in London, Medicsight is a subsidiary of MGT Capital Investments, Inc.
For more information, please visit www.medicsight.com.

MGT Capital Investments, Inc. is a technology holding company that focuses on investments in the global healthcare information technology market. The company has two subsidiaries, Medicsight and Medicexchange.
For more information please visit www.mgtci.com.

Clinivation is the leading provider of integrated solutions that enable global market clearance. Guided by our singular vision - "Excellence in Market Clearance" - clinivation accelerates the entire market clearance cycle to advance new worldwide revenue and achieve new milestones of enterprise value.

Used in over 100,000 product registrations by more than 100 companies worldwide, clinivation's end-to-end technology and services deliver on our vision by eliminating revenue traps from global market clearance operations, increasing process velocity with on-demand regulatory intelligence, automating clearance-driven business controls, simplifying content unification into market clearance applications, aligning quality systems with global market clearance priorities, streamlining clinical development with clearance-focused trials, and enabling management with key performance indicators for continuous improvement and effective governance.

The world's leading medical device, diagnostics, hospital supply, and dental supply companies select clinivation because of our medtech industry focus and our unique, integrated solutions that seamlessly adapt to existing business processes and enterprise infrastructure- without the need to write custom code.

Our core brands include the clinivation Global^® xi market clearance platform, clinivation WorldView^® on-demand regulatory intelligence, and clinivation Clinical Suite^® and clinivation Registry Suite^® electronic data capture and clinical data management software.

Founded in 1999, the company is headquartered in Natick, Massachusetts, with regional offices in North America and Asia.

Visit clinivation online at www.clinivation.com

For more information on clinivation's integrated solutions that enable global market clearance, please click here or call us at 508.655.6560.